NEW YORK (GenomeWeb) – Sequencing healthy individuals as a way to assess their risk of serious, heritable conditions has been primarily an academic exercise, years away from being implemented broadly. But, as the costs of sequencing continue to decline and sequencing-based tests become more and more accepted in the clinic, the idea of using the technology to do population-based screening is not as far fetched as it once was.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.